「was」の検索結果
29件：16～20件目を表示
-
CEO Message | About Senju | SENJU Pharmaceutical
Since Senju was established in 1947, we have been making efforts for more than 70 years to develop excellent medicines and services focusing on the ophthalmology field through our unique ideas and R&a...
https://www.senju.co.jp/english/about/message.html -
the orphan drug designation to the in-house developed compound having the development code SJP-0008 was granted by the Ministry of Health, Labor and Welfare (HMLW) on June 19, 2024, as an orphan drug ...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708.pdf -
1回1滴で、充血クリアｌマイティアルミファイｌ千寿製薬
2 投与1４日目の結膜充血スコアの推移 （平均値 ± 標準誤差）（Full Analysis Set） ※Use of the ORA Calibra Redness/Hyperemia Scale was made under license from Ora,Inc 安全性 ＋ ー 安全性評価において、副作用として本品群109人中1人（0.9%）に軽度の眼圧低下が認められましたが、発現後も本品...
https://www.senju.co.jp/consumer/mytearlumify -
the orphan drug designation to the in-house developed compound having the development code SJP-0008 was granted by the Ministry of Health, Labor and Welfare (HMLW) on June 19, 2024, as an orphan drug ...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708_0.pdf -
CEO Message | About Senju | SENJU Pharmaceutical
Since Senju was established in 1947, we have been making efforts for more than 70 years to develop excellent medicines and services focusing on the ophthalmology field through our unique ideas and R&a...
http://www.senju.co.jp/english/about/message.html